Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Impaired Degradation of Mutant -Synuclein by Chaperone-Mediated Autophagy
Ana Maria Cuervo,1*Leonidas Stefanis,2Ross Fredenburg,3Peter T. Lansbury,3David Sulzer4
Aberrant -synuclein degradation is implicated in Parkinson'sdisease pathogenesis because the protein accumulates in theLewy inclusion bodies associated with the disease. Little isknown, however, about the pathways by which wild-type -synucleinis normally degraded. We found that wild-type -synuclein wasselectively translocated into lysosomes for degradation by thechaperone-mediated autophagy pathway. The pathogenic A53T andA30P -synuclein mutants bound to the receptor for this pathwayon the lysosomal membrane, but appeared to act as uptake blockers,inhibiting both their own degradation and that of other substrates.These findings may underlie the toxic gain-of-function by themutants.
1 Department of Anatomy and Structural Biology, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA. 2 Neurobiology Laboratory, Foundation of Biomedical Research of the Academy of Athens, Athens 11527, Greece and Department of Neurology and Pathology, Columbia University, New York, NY 10032, USA. 3 Center for Neurologic Diseases, Brigham and Women's Hospital, Department of Neurology, Harvard MedicalSchool, Cambridge, MA 02139, USA. 4 Departments of Psychiatry and Neurology, Columbia University, Department of Neuroscience, New York State Psychiatric Institute, New York, NY 10032, USA.
* To whom correspondence should be addressed. E-mail: amcuervo{at}aecom.yu.edu
Effect of autophagy on multiple myeloma cell viability.
B. Hoang, A. Benavides, Y. Shi, P. Frost, and A. Lichtenstein (2009)
Mol. Cancer Ther.
8, 1974-1984
|Abstract »|Full Text »|PDF »
Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy.
S. Shen, P. Zhang, M. A. Lovchik, Y. Li, L. Tang, Z. Chen, R. Zeng, D. Ma, J. Yuan, and Q. Yu (2009)
J. Cell Biol.
185, 629-639
|Abstract »|Full Text »|PDF »
Protective Role of Endogenous Gangliosides for Lysosomal Pathology in a Cellular Model of Synucleinopathies.
J. Wei, M. Fujita, M. Nakai, M. Waragai, A. Sekigawa, S. Sugama, T. Takenouchi, E. Masliah, and M. Hashimoto (2009)
Am. J. Pathol.
174, 1891-1909
|Abstract »|Full Text »|PDF »
Phosphorylation does not prompt, nor prevent, the formation of {alpha}-synuclein toxic species in a rat model of Parkinson's disease.
S. Azeredo da Silveira, B. L. Schneider, C. Cifuentes-Diaz, D. Sage, T. Abbas-Terki, T. Iwatsubo, M. Unser, and P. Aebischer (2009)
Hum. Mol. Genet.
18, 872-887
|Abstract »|Full Text »|PDF »
The Drosophila BEACH Family Protein, Blue Cheese, Links Lysosomal Axon Transport with Motor Neuron Degeneration.
Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy.
Q. Yang, H. She, M. Gearing, E. Colla, M. Lee, J. J. Shacka, and Z. Mao (2009)
Science
323, 124-127
|Abstract »|Full Text »|PDF »
Aberrant Interaction between Parkinson Disease-associated Mutant UCH-L1 and the Lysosomal Receptor for Chaperone-mediated Autophagy.
T. Kabuta, A. Furuta, S. Aoki, K. Furuta, and K. Wada (2008)
J. Biol. Chem.
283, 23731-23738
|Abstract »|Full Text »|PDF »
Wild Type {alpha}-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells.
T. Vogiatzi, M. Xilouri, K. Vekrellis, and L. Stefanis (2008)
J. Biol. Chem.
283, 23542-23556
|Abstract »|Full Text »|PDF »
Autophagy-mediated clearance of aggresomes is not a universal phenomenon.
E. S.P. Wong, J. M.M. Tan, W.-E Soong, K. Hussein, N. Nukina, V. L. Dawson, T. M. Dawson, A. M. Cuervo, and K.-L. Lim (2008)
Hum. Mol. Genet.
17, 2570-2582
|Abstract »|Full Text »|PDF »
The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
{alpha}-Synuclein Protofibrils Inhibit 26 S Proteasome-mediated Protein Degradation: UNDERSTANDING THE CYTOTOXICITY OF PROTEIN PROTOFIBRILS IN NEURODEGENERATIVE DISEASE PATHOGENESIS.
N.-Y. Zhang, Z. Tang, and C.-W. Liu (2008)
J. Biol. Chem.
283, 20288-20298
|Abstract »|Full Text »|PDF »
Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease.
B. Boland, A. Kumar, S. Lee, F. M. Platt, J. Wegiel, W. H. Yu, and R. A. Nixon (2008)
J. Neurosci.
28, 6926-6937
|Abstract »|Full Text »|PDF »
Progress in the pathogenesis and genetics of Parkinson's disease.
Y. Mizuno, N. Hattori, S.-i. Kubo, S. Sato, K. Nishioka, T. Hatano, H. Tomiyama, M. Funayama, Y. Machida, and H. Mochizuki (2008)
Phil Trans R Soc B
363, 2215-2227
|Abstract »|Full Text »|PDF »
The Reaction of {alpha}-Synuclein with Tyrosinase: POSSIBLE IMPLICATIONS FOR PARKINSON DISEASE.
I. Tessari, M. Bisaglia, F. Valle, B. Samori, E. Bergantino, S. Mammi, and L. Bubacco (2008)
J. Biol. Chem.
283, 16808-16817
|Abstract »|Full Text »|PDF »
Gaucher and Parkinson diseases: Unexpectedly related.
E. Rogaeva and J. Hardy (2008)
Neurology
70, 2272-2273
|Full Text »|PDF »
Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
T. Kabuta, R. Setsuie, T. Mitsui, A. Kinugawa, M. Sakurai, S. Aoki, K. Uchida, and K. Wada (2008)
Hum. Mol. Genet.
17, 1482-1496
|Abstract »|Full Text »|PDF »
Constitutive Activation of Chaperone-mediated Autophagy in Cells with Impaired Macroautophagy.
S. Kaushik, A. C. Massey, N. Mizushima, and A. M. Cuervo (2008)
Mol. Biol. Cell
19, 2179-2192
|Abstract »|Full Text »|PDF »
Elevated {alpha}-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
J. Grundemann, F. Schlaudraff, O. Haeckel, and B. Liss (2008)
Nucleic Acids Res.
36, e38
|Abstract »|Full Text »|PDF »
Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease.
S. Nuber, E. Petrasch-Parwez, B. Winner, J. Winkler, S. von Horsten, T. Schmidt, J. Boy, M. Kuhn, H. P. Nguyen, P. Teismann, et al. (2008)
J. Neurosci.
28, 2471-2484
|Abstract »|Full Text »|PDF »
Lithium delays progression of amyotrophic lateral sclerosis.
F. Fornai, P. Longone, L. Cafaro, O. Kastsiuchenka, M. Ferrucci, M. L. Manca, G. Lazzeri, A. Spalloni, N. Bellio, P. Lenzi, et al. (2008)
PNAS
105, 2052-2057
|Abstract »|Full Text »|PDF »
Monoubiquitylation of {alpha}-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells.
R. Rott, R. Szargel, J. Haskin, V. Shani, A. Shainskaya, I. Manov, E. Liani, E. Avraham, and S. Engelender (2008)
J. Biol. Chem.
283, 3316-3328
|Abstract »|Full Text »|PDF »
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.
S. Hamamichi, R. N. Rivas, A. L. Knight, S. Cao, K. A. Caldwell, and G. A. Caldwell (2008)
PNAS
105, 728-733
|Abstract »|Full Text »|PDF »
Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss in Drosophila Models of Parkinson's Disease.
K. Trinh, K. Moore, P. D. Wes, P. J. Muchowski, J. Dey, L. Andrews, and L. J. Pallanck (2008)
J. Neurosci.
28, 465-472
|Abstract »|Full Text »|PDF »
Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies.
J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto (2007)
J. Biol. Chem.
282, 28904-28914
|Abstract »|Full Text »|PDF »
Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese.
Y.-R. Wu, C.-M. Chen, C.-Y. Chao, L.-S. Ro, R.-K. Lyu, K.-H. Chang, and G.-J. Lee-Chen (2007)
J. Neurol. Neurosurg. Psychiatry
78, 977-979
|Abstract »|Full Text »|PDF »
Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation.
A. J. Lees and A. B. Singleton (2007)
Neurology
68, 1553-1554
|Full Text »|PDF »
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
A. Di Fonzo, H. F. Chien, M. Socal, S. Giraudo, C. Tassorelli, G. Iliceto, G. Fabbrini, R. Marconi, E. Fincati, G. Abbruzzese, et al. (2007)
Neurology
68, 1557-1562
|Abstract »|Full Text »|PDF »
Translocation of {alpha}-Synuclein Expressed in Escherichia coli.
G. Ren, X. Wang, S. Hao, H. Hu, and C.-c. Wang (2007)
J. Bacteriol.
189, 2777-2786
|Abstract »|Full Text »|PDF »
Influence of autophagy genes on ion-channel-dependent neuronal degeneration in Caenorhabditis elegans.
M. L. Toth, P. Simon, A. L. Kovacs, and T. Vellai (2007)
J. Cell Sci.
120, 1134-1141
|Abstract »|Full Text »|PDF »
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.
A. Eslamboli, M. Romero-Ramos, C. Burger, T. Bjorklund, N. Muzyczka, R. J. Mandel, H. Baker, R. M. Ridley, and D. Kirik (2007)
Brain
130, 799-815
|Abstract »|Full Text »|PDF »
Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and {alpha}-Synuclein.
S. Sarkar, J. E. Davies, Z. Huang, A. Tunnacliffe, and D. C. Rubinsztein (2007)
J. Biol. Chem.
282, 5641-5652
|Abstract »|Full Text »|PDF »
{alpha}-Synuclein Stimulates Differentiation of Osteosarcoma Cells: RELEVANCE TO DOWN-REGULATION OF PROTEASOME ACTIVITY.
M. Fujita, S. Sugama, M. Nakai, T. Takenouchi, J. Wei, T. Urano, S. Inoue, and M. Hashimoto (2007)
J. Biol. Chem.
282, 5736-5748
|Abstract »|Full Text »|PDF »
Pesticide Exposure Exacerbates {alpha}-Synucleinopathy in an A53T Transgenic Mouse Model.
E. H. Norris, K. Uryu, S. Leight, B. I. Giasson, J. Q. Trojanowski, and V. M.-Y. Lee (2007)
Am. J. Pathol.
170, 658-666
|Abstract »|Full Text »|PDF »
Regulation of Autophagy by Extracellular Signal-Regulated Protein Kinases During 1-Methyl-4-Phenylpyridinium-Induced Cell Death.
J.-h. Zhu, C. Horbinski, F. Guo, S. Watkins, Y. Uchiyama, and C. T. Chu (2007)
Am. J. Pathol.
170, 75-86
|Abstract »|Full Text »|PDF »
{beta}-synuclein modulates {alpha}-synuclein neurotoxicity by reducing {alpha}-synuclein protein expression.
Y. Fan, P. Limprasert, I. V.J. Murray, A. C. Smith, V. M.-Y. Lee, J. Q. Trojanowski, B. L. Sopher, and A. R. La Spada (2006)
Hum. Mol. Genet.
15, 3002-3011
|Abstract »|Full Text »|PDF »
Degradation of Amyotrophic Lateral Sclerosis-linked Mutant Cu,Zn-Superoxide Dismutase Proteins by Macroautophagy and the Proteasome.
S. Finkbeiner, A. Maria Cuervo, R. I. Morimoto, and P. J. Muchowski (2006)
J. Neurosci.
26, 10349-10357
|Full Text »|PDF »
Endoplasmic Reticulum Stress Triggers Autophagy.
T. Yorimitsu, U. Nair, Z. Yang, and D. J. Klionsky (2006)
J. Biol. Chem.
281, 30299-30304
|Abstract »|Full Text »|PDF »
Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells.
A. Klegeris, B. I. Giasson, H. Zhang, J. Maguire, S. Pelech, and P. L. McGeer (2006)
FASEB J
20, 2000-2008
|Abstract »|Full Text »|PDF »
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.
O. Goker-Alpan, B. I. Giasson, M. J. Eblan, J. Nguyen, H. I. Hurtig, V. M.-Y. Lee, J. Q. Trojanowski, and E. Sidransky (2006)
Neurology
67, 908-910
|Abstract »|Full Text »|PDF »
E. V. Mosharov, R. G. W. Staal, J. Bove, D. Prou, A. Hananiya, D. Markov, N. Poulsen, K. E. Larsen, C. M. H. Moore, M. D. Troyer, et al. (2006)
J. Neurosci.
26, 9304-9311
|Abstract »|Full Text »|PDF »
Consequences of the selective blockage of chaperone-mediated autophagy.
A. C. Massey, S. Kaushik, G. Sovak, R. Kiffin, and A. M. Cuervo (2006)
PNAS
103, 5805-5810
|Abstract »|Full Text »|PDF »
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy..
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al. (2006)
J. Neurosci.
26, 3685-3696
|Abstract »|Full Text »|PDF »
Prolyl-isomerase Pin1 Accumulates in Lewy Bodies of Parkinson Disease and Facilitates Formation of {alpha}-Synuclein Inclusions.
A. Ryo, T. Togo, T. Nakai, A. Hirai, M. Nishi, A. Yamaguchi, K. Suzuki, Y. Hirayasu, H. Kobayashi, K. Perrem, et al. (2006)
J. Biol. Chem.
281, 4117-4125
|Abstract »|Full Text »|PDF »
Mutations in the glucocerebrosidase gene and Parkinson disease: Phenotype-genotype correlation.
J. Aharon-Peretz, S. Badarny, H. Rosenbaum, and R. Gershoni-Baruch (2005)
Neurology
65, 1460-1461
|Abstract »|Full Text »|PDF »
Macroautophagy--a novel {beta}-amyloid peptide-generating pathway activated in Alzheimer's disease.
W. H. Yu, A. M. Cuervo, A. Kumar, C. M. Peterhoff, S. D. Schmidt, J.-H. Lee, P. S. Mohan, M. Mercken, M. R. Farmery, L. O. Tjernberg, et al. (2005)
J. Cell Biol.
171, 87-98
|Abstract »|Full Text »|PDF »
Lithium induces autophagy by inhibiting inositol monophosphatase.
S. Sarkar, R. A. Floto, Z. Berger, S. Imarisio, A. Cordenier, M. Pasco, L. J. Cook, and D. C. Rubinsztein (2005)
J. Cell Biol.
170, 1101-1111
|Abstract »|Full Text »|PDF »
Familial Mutants of {alpha}-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation.
C. W. Bertoncini, C. O. Fernandez, C. Griesinger, T. M. Jovin, and M. Zweckstetter (2005)
J. Biol. Chem.
280, 30649-30652
|Abstract »|Full Text »|PDF »
The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates {alpha}-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways.
Y. Shin, J. Klucken, C. Patterson, B. T. Hyman, and P. J. McLean (2005)
J. Biol. Chem.
280, 23727-23734
|Abstract »|Full Text »|PDF »
A Precipitating Role for Truncated {alpha}-Synuclein and the Proteasome in {alpha}-Synuclein Aggregation: IMPLICATIONS FOR PATHOGENESIS OF PARKINSON DISEASE.
C.-W. Liu, B. I. Giasson, K. A. Lewis, V. M. Lee, G. N. DeMartino, and P. J. Thomas (2005)
J. Biol. Chem.
280, 22670-22678
|Abstract »|Full Text »|PDF »
Structure and Dynamics of Micelle-bound Human {alpha}-Synuclein.
T. S. Ulmer, A. Bax, N. B. Cole, and R. L. Nussbaum (2005)
J. Biol. Chem.
280, 9595-9603
|Abstract »|Full Text »|PDF »
The Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews.
M. J. Eblan, J. M. Walker, E. Sidransky, A. Zimran, O. Neudorfer, D. Elstein, M. G. Schlossmacher, V. Cullen, J. Muthing, R. Gershoni-Baruch, et al. (2005)
N. Engl. J. Med.
352, 728-731
|Full Text »|PDF »
Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila.
P. K. Auluck, M. C. Meulener, and N. M. Bonini (2005)
J. Biol. Chem.
280, 2873-2878
|Abstract »|Full Text »|PDF »